Icare is the market leader in tonometers for intraocular pressure screening. The foundation for profitable growth is its unique, industry-leading technology combined with a global distribution network.
The Icare product family is protected by more than 20 different international patents. The company’s R&D team is continuously working for introducing more new products for new target groups.
It is estimated that 150 million people suffer from glaucoma, approximately half of them without knowing it.
Icare is the market leader in tonometers, based on superior rebound technology for intraocular pressure screening. The foundation for profitable growth is its unique, industry-leading technology combined with a global distribution network.
Icare’s tonometers are developed and manufactured in Finland. The growing market potential is, however, not limited to certain countries or continents, as the aging and growth of the population increase the risk for glaucoma everywhere. The challenge is the same: healthcare must be made more efficient and more productive, and expensive specialist healthcare and know-how will never reach everyone who needs them. At the same time, information on the increasing prevalence of diseases like glaucoma is spreading, and the need for treatment and patient-oriented intraocular pressure screenings increase.
Population aging and growth increase the risk of glaucoma everywhere.
Ease of use is a component of quality
The Icare product family’s tonometers are fast, reliable, accurate and easy-to-use
measurement to detect and follow-up glaucoma. The use of tonometers does not require anesthetization of the patient’s eye or specialist ophthalmological expertise.
Eye diseases are traditionally examined by specialists. As patient-oriented screenings are becoming more common, tonometers are increasingly becoming tools for general practitioners, opticians, optometrists, first-aid staff and and the field workers of international aid organizations.
Important user groups are also the health care personnel working with child patients as well as in the vet clinics. In addition to people, the Icare tonometer can be used for intraocular pressure screenings on animals. The growth potential in these target groups is significant.
Home measurement increases reliability
Home measurements make glaucoma monitoring more reliable because intraocular pressure may fluctuate a lot at different times of the day. For monitoring data to be reliable, measurements are needed at different times of the day. In these cases, home monitoring is less cumbersome for the patient as the traditional hospitalization.
Round-the-clock monitoring of intraocular pressure makes the Icare HOME tonometer, designed for self-monitoring, available to glaucoma patients. The mHOME mobile application connects patients, who measure their intraocular pressure at home, to their doctor via a cloud service.